Advanced Search

    column
    Thrombotic Disease Management and Precision Medication: Clinical Practice and Exploration
    PAN Mangmang, LIANG Liju, CAI Tanling, ZHANG Chi, GU Zhichun
    2026, 43(4): 541-546. DOI: 10.13748/j.cnki.issn1007-7693.20260374
    Abstract PDF
    Chinese Expert Consensus on the Clinical Application of Low Molecular Weight Heparins
    Precision Pharmacy Working Committee of the Chinese Pharmacist Association, Expert Panel of the Chinese Expert Consensus on the Clinical Application of Low Molecular Weight Heparins
    2026, 43(4): 547-565. DOI: 10.13748/j.cnki.issn1007-7693.20252043
    Abstract PDF
    Low Molecular Weight Heparin in the Treatment of Recurrent Spontaneous Abortion: Advances and Controversies
    CHEN Lei, CAI Tanling, SHI Yue, GU Zhichun, ZHANG Chi, LIU Li, HU Meng, PAN Mangmang, LIN Houwen
    2026, 43(4): 566-572. DOI: 10.13748/j.cnki.issn1007-7693.20252598
    Abstract PDF
    Establishment of a Clinical Comprehensive Evaluation System for Low Molecular Weight Heparin in the Prevention and Treatment of Recurrent Spontaneous Abortion
    CHEN Lei, CAI Tanling, SHI Yue, GU Zhichun, ZHANG Chi, LIU Li, HU Meng, PAN Mangmang, LIN Houwen
    2026, 43(4): 573-579. DOI: 10.13748/j.cnki.issn1007-7693.20253193
    Abstract PDF
    Investigation and Analysis of Medication Information for Special Populations in Package Inserts and Guidelines/Consensuses of Low Molecular Weight Heparin Preparations for Prevention of Venous Thromboembolism
    CHEN Shubin, CHEN Eryang, HUANG Rong, HUANG Yuye
    2026, 43(4): 580-588. DOI: 10.13748/j.cnki.issn1007-7693.20252851
    Abstract PDF
    Controversies and Advances in Perioperative Bridging with Low Molecular Weight Heparin for Noncardiac Surgery in Patients on Dual Antiplatelet Therapy After PCI
    PENG Xueying, ZHOU Lin, LI Yangling, XU Hang
    2026, 43(4): 589-594. DOI: 10.13748/j.cnki.issn1007-7693.20252726
    Abstract PDF
    Effect of Renal Function for Excessive Anticoagulation with Warfarin in Patients with Atrial Fibrillation
    LIU Lili, XU Kun, LI Zhengrong, LIU Ying
    2026, 43(4): 595-600. DOI: 10.13748/j.cnki.issn1007-7693.20252679
    Abstract PDF
    Anticoagulant Therapy for Venous Thromboembolism in Children with Renal Insufficiency
    LI Ping, YAN Meixing, LIU Dehui, YU Hongli
    2026, 43(4): 601-608. DOI: 10.13748/j.cnki.issn1007-7693.20252570
    Abstract PDF
    Evaluation of the Efficacy and Safety of Rivaroxaban in Prophylactic Anticoagulant Therapy for Nephrotic Syndrome
    MEI Qian, CHEN Qi, LI Li
    2026, 43(4): 609-615. DOI: 10.13748/j.cnki.issn1007-7693.20252733
    Abstract PDF
    Individualized Decision-making for Anticoagulation During Pregnancy After Valve Replacement: A Clinical Reflection
    HONG Mianhui, FAN Linjun, WU Danna
    2026, 43(4): 616-620. DOI: 10.13748/j.cnki.issn1007-7693.20252738
    Abstract PDF
    Personalized Antiplatelet Therapy and Pharmaceutical Care in Pediatric Acute Ischemic Stroke
    ZHAO Huawei, CHEN Jie, YU Lingyan, XU Huifen, MIAO Jing, DAI Haibin
    2026, 43(4): 621-626. DOI: 10.13748/j.cnki.issn1007-7693.20251798
    Abstract PDF
    Antithrombotic Treatment Strategy for Gemcitabine-Induced Thrombocytosis: Case Reports and Literature Review
    YAN Yidan, SU Yingjie, LUO Xiaofeng, LAN Ying
    2026, 43(4): 627-630. DOI: 10.13748/j.cnki.issn1007-7693.20252270
    Abstract PDF
    Effect Evaluation and Practice of Anti-thrombotic Pharmacy Consultation Oriented Towards Medicine Related Problems Based on Medication Therapy Management
    LI Li, ZOU Su, MEI Qian, XIONG Shijuan, CHEN Qi, XIE Juan, QIAN Xin
    2026, 43(4): 631-639. DOI: 10.13748/j.cnki.issn1007-7693.20252824
    Abstract PDF
    Analysis of Antithrombotic Therapy Involving Clinical Pharmacists in a Patient with Systemic Lupus Erythematosus Complicated by Acute Cerebral Infarction with Hemorrhagic Transformation
    LIU Xianghong, ZHANG Rong, LI Li
    2026, 43(4): 640-644. DOI: 10.13748/j.cnki.issn1007-7693.20252689
    Abstract PDF
    Clinical Pharmacists Participated in Individualized Treatment of a Patient with Thrombotic Thrombocytopenic Purpura
    MEI Qian, CHEN Qi, XIONG Shijuan, QIAN Xin
    2026, 43(4): 645-651. DOI: 10.13748/j.cnki.issn1007-7693.20252748
    Abstract PDF
    Clinical Pharmacists Participated in the Pharmaceutical Practice of Adjusting the Antithrombotic Regimen for a Patient with Atrial Fibrillation and Long-term Hemodialysis Status After Percutaneous Coronary Intervention
    SUN Xin, WANG Hui, ZHU Zhu, WANG Li, ZHAO Bin
    2026, 43(4): 652-658. DOI: 10.13748/j.cnki.issn1007-7693.20252765
    Abstract PDF
    Pharmaceutical Practice of Clinical Pharmacist in Anticoagulant Therapy for a Postoperative Bioprosthetic Valve Patient with Suspected Heparin-induced Thrombocytopenia
    CHEN Hui, ZHOU Qiang, SUN Lei, WANG Changtian, WEI Meng
    2026, 43(4): 659-663. DOI: 10.13748/j.cnki.issn1007-7693.20252935
    Abstract PDF
    Clinical Pharmacists Participated in Pharmaceutical Practice of Standardized Anticoagulant for Elderly Patients with Non-valvular Atrial Fibrillation
    ZHENG Xiaoyuan, ZHANG Mingzhu, NI Jiang, WU Xiufeng, LYU Juan, XIE Fen
    2026, 43(4): 664-672. DOI: 10.13748/j.cnki.issn1007-7693.20252737
    Abstract PDF
    Safety Evaluation of Anticoagulants Based on Regional Surveillance Data
    LI Xiaoyao, ZENG Jianping, WANG Jun
    2026, 43(4): 673-680. DOI: 10.13748/j.cnki.issn1007-7693.20252740
    Abstract PDF
    Investigation and Study on Anticoagulant Knowledge and Service Competence of Community Pharmacists
    PAN Mangmang, ZHANG Chi, WANG Jia, WANG Xin, SHEN Long, XU Ke, SHA Jingjing, CHENG Jiayue, GU Zhichun
    2026, 43(4): 681-687. DOI: 10.13748/j.cnki.issn1007-7693.20253241
    Abstract PDF
    “Human-AI Coexistence” Paradigm-based Management of Thrombotic Diseases: Theoretical Framework, Clinical Applications, and Challenges
    GU Zhichun, PAN Mangmang, ZHANG Chi, WANG Jia, WANG Xin, HU Meng, YAN Yidan, SHEN Long, KONG Lingcong, LU Jiao
    2026, 43(4): 688-696. DOI: 10.13748/j.cnki.issn1007-7693.20252736
    Abstract PDF
    Application and Effect Evaluation of “Human-GenAI Coexistence” Management Model in NOAC Therapy for Patients with Atrial Fibrillation
    LI Zhike, LIANG Liju, CAI Tanling, CAO Yu, SHEN Long, ZHENG Ping, ZHANG Chi, GU Zhichun, PAN Mangmang
    2026, 43(4): 697-704. DOI: 10.13748/j.cnki.issn1007-7693.20252727
    Abstract PDF
    Development and Preliminary Evaluation of a PEAC Model-based Pharmaceutical Care Service Model for Perioperative VTE Management in Orthopedics
    HUANG Guili, WANG Yalan, ZHU Jun, ZHANG Rui, DU Qian, DONG Jie
    2026, 43(4): 705-712. DOI: 10.13748/j.cnki.issn1007-7693.20252633
    Abstract PDF
    Construction of a Closed-loop Intelligent Prevention and Treatment System for Stroke Based on the Concept of “Front-loading Prevention”
    YAN Shan, WU Hengqu, HU Xiaoxia, JI Yajun, ZHANG Bei, YANG Sendian, ZHANG Ying, GUAN Yangtai
    2026, 43(4): 713-720. DOI: 10.13748/j.cnki.issn1007-7693.20252717
    Abstract PDF